Citadel Advisors’s Chembio diagnostics, Inc. CEMI Stock Holding History

Citadel Advisors’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-22,100	Closed	-$9.77K	–	15811
2023 Q1	$9.77K	Sell	22,100 -19,400	-47%	-$7.6K	﹤0.01%	13565
2022 Q4	$9.12K	Sell	41,500 -1,600	-4%	-$478	﹤0.01%	13705
2022 Q3	$16K	Buy	43,100 +24,400	+130%	+$16.6K	﹤0.01%	12157
2022 Q2	$12K	Sell	18,700 -4,300	-19%	-$2.86K	﹤0.01%	12558
2022 Q1	$19K	Sell	23,000 -2,900	-11%	-$2.71K	﹤0.01%	13264
2021 Q4	$30K	Sell	25,900 -27,700	-52%	-$56.4K	﹤0.01%	13484
2021 Q3	$134K	Buy	53,600 +24,300	+83%	+$67.4K	﹤0.01%	12513
2021 Q2	$87K	Sell	29,300 -57,500	-66%	-$200K	﹤0.01%	13030
2021 Q1	$305K	Buy	86,800 +41,300	+91%	+$230K	﹤0.01%	10825
2020 Q4	$216K	Sell	45,500 -19,400	-30%	-$100K	﹤0.01%	9625
2020 Q3	$315K	Buy	64,900 +52,000	+403%	+$246K	﹤0.01%	8051
2020 Q2	$42K	Buy	+12,900	New	+$122K	﹤0.01%	9384

Other funds holding CEMI

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Citadel Advisors's CEMI Position: Q2 2023 in Review

Citadel Advisors sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2023, closing a stake of 1,409 shares — an estimated $623 sold.

Citadel Advisors first reported a position in CEMI in Q1 2014 and held it in 15 quarters. The position peaked at $439K in Q3 2020. 1 fund tracked by Wall St. Rank holds CEMI as of Q2 2023.

Citadel Advisors reported no remaining Chembio diagnostics, Inc. position as of Q2 2023 after selling out during the quarter.
Citadel Advisors sold 1,409 Chembio diagnostics, Inc. shares in Q2 2023, an estimated $623.
Citadel Advisors first reported a position in Chembio diagnostics, Inc. in Q1 2014 and held it in 15 quarters.
Citadel Advisors's Chembio diagnostics, Inc. position peaked at $439K in Q3 2020.
1 fund tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2023.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.